Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

RECRUITING NA

Hydrocolloid Dressings for Oculofacial Plastic and Reconstructive Wound Healing

NCT07075159 · View on ClinicalTrials.gov ↗

Study Summary

This study aims to explore the use of a hydrocolloid dressing (DuoDERM EXTRA THIN) as an alternative to the current standard of care. The dressing would be applied immediately after surgery and removed at a post-operative week 1 appointment. The dressing would eliminate the need for antibiotic ointment application and reduce the burden of post-operative care on the patient.

Interventions

  • DEVICE Hydrocolloid Wound Dressing

Study Locations (1)

Kentucky

  • University of Kentucky — Lexington

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2025-02-28
Est. Completion 2026-09-01
Phase NA

Sponsor

Janice Hernandez, MD

1 total trials

Interested in This Trial?

Always speak with your doctor before enrolling in a clinical trial.

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07075159

The ClinicalTrials.gov registry entry for NCT07075159 describes a study currently listed as recruiting. It is categorized as NA, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Janice Hernandez, MD, which has 1 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.

The record links to 3 conditions, with Wound Healing appearing as the primary indexed condition, and to 1 intervention — of which Hydrocolloid Wound Dressing is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.

Geographic footprint matters for practical reasons: NCT07075159 reports 1 study location spanning 1 distinct geographic area — top geographies include Kentucky. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.

Frequently Asked Questions

What is clinical trial NCT07075159 about?

NCT07075159 is a clinical study titled "Hydrocolloid Dressings for Oculofacial Plastic and Reconstructive Wound Healing". This study aims to explore the use of a hydrocolloid dressing (DuoDERM EXTRA THIN) as an alternative to the current standard of care. The dressing would be applied immediately after surgery and removed at a post-operative week 1 appointment. The dressing would eliminate the need for antibiotic ointm...

What is the current status of trial NCT07075159?

This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2025-02-28. Estimated completion is 2026-09-01.

What conditions does trial NCT07075159 study?

This clinical trial studies the following conditions: Wound Healing, Mohs Micrographic Surgery, Oculofacial Reconstruction. These conditions were identified from the trial registry and reflect the primary focus areas of the research.

What interventions are being tested in trial NCT07075159?

The interventions under investigation include: Hydrocolloid Wound Dressing (DEVICE). Each intervention is being evaluated for safety and efficacy as part of this clinical study.

Who is sponsoring clinical trial NCT07075159?

This trial is sponsored by Janice Hernandez, MD, which has 1 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.

Where is trial NCT07075159 being conducted?

This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Related

Data sourced from official U.S. government datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial